FUS and amyotrophic lateral sclerosis: Targeting the DDR pathways that are defective, whether through DNA repair enhancers or ROS scavengers, is a possible therapeutic route to reduce DNA-damage-related genome instability and slow the progression of FUS-associated ALS [183].